대한약학회:학술대회논문집 (Proceedings of the PSK Conference)
- 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
- /
- Pages.149.2-149.2
- /
- 2003
A Collaborative Study to Establish a Korea National Biological Standard for Antithrombin III Concentrate
- Kang, Hye-Na (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administration) ;
- Oh, Ho-Jung (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administratio) ;
- Kim, Soon-Nam (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administratio) ;
- Hong, Choong-Man (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administratio) ;
- Lee, Ki-Hong (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administratio) ;
- Yoo, Si-Hyung (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administratio) ;
- Shin, In-Soo (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administratio) ;
- Choi, Seung-Eun (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administratio) ;
- Lee, Seok-Ho (Blood Products Division, Biologics Evaluation Department, Korea Food and Drug Administration)
- 발행 : 2003.04.01
초록
We have carried out a collaborative study to evaluate a candidate preparation of antithrombin III concentrate whether it is suitable to serve as a Korea National Biological Standard. Three National Control Laboratories and three manufacturers participated in this study. The potency of this candidate preparation was determined by using a heparin cofactor chromogenic method described in the Minimum Requirements for Biological Products and the European Phamacopoeia. (omitted)
키워드